Differin is a topical retinoid medication used primarily for the treatment of acne vulgaris. It contains the active ingredient adapalene which exerts its effects on the skin by modulating keratinocyte differentiation. The drug binds to specific nuclear receptors that regulate gene expression involved in cell proliferation and inflammation. This interaction leads to a reduction in the formation of comedones by decreasing follicular plugging and sebum-related follicular hyperkeratosis. Additionally adapalene inhibits the release of pro-inflammatory cytokines that contribute to erythema and papular lesions. The resulting normalization of skin cell turnover promotes clearing of existing lesions and helps prevent new lesions from developing. Unlike some other retinoids adapalene has a high affinity for the retinoic acid receptor beta which contributes to its efficacy with minimal systemic absorption. Over time consistent topical application results in smoother skin texture and a marked decrease in acne severity.

Differin is a topical medication that contains adapalene, a synthetic retinoid used in dermatology. It is indicated primarily for the treatment of acne vulgaris in patients aged twelve years and older. The drug works by modulating the growth and differentiation of keratinocytes in the skin. Adapalene binds to retinoic acid receptors, influencing gene expression that regulates cell proliferation and inflammation. This interaction reduces the formation of comedones by normalizing follicular epithelial cell turnover. The anti-inflammatory effect stems from the inhibition of cytokines that contribute to the development of papules and pustules. By promoting the rapid exfoliation of the stratum corneum, Differin clears clogged pores while minimizing irritation. The combined actions of these mechanisms lead to a visible reduction in acne lesions over weeks of consistent application.

Differin may cause mild skin irritation at the application site. Some users experience dryness, peeling, or flaking of the skin. A tingling or burning sensation can occur during the initial treatment period. Redness or slight swelling is also a possible reaction. In rare cases, contact dermatitis may develop from hypersensitivity. Most symptoms improve as the skin adjusts to the medication.

Differin may cause mild skin irritation in some users. Dryness of the treated area is a frequent occurrence. Redness or flushing can appear shortly after application. Peeling of the skin often develops as the treatment progresses. Itching or a sensation of tightness may be felt temporarily. A mild burning feeling sometimes occurs without serious harm. These reactions typically lessen with continued use.